Abstract
With a prevalence ranging from 16-21%, tinnitus is an irking neurological disorder, manifesting
as the perception of a roar of cacophony without an external acoustic stimulus. Although
tinnitus is a non-life-threatening symptom, tinnitus's negative repercussions, such as personality disturbances
and social withdrawal, are daunting concerns despite a gamut of conventional and emerging
treatment options. Tinnitus management is still a critical challenge that provides opportunities
for clinicians, ENT (Ear/eye, nose and throat) physicians, and other specialists such as audiologists,
psychiatrists, and psychologists. Among the new treatment modalities, Neuromonics tinnitus
treatment (NTT) draws special attention in tinnitus management due to its mounting success rate.
Nonetheless, unlike in developed countries like Australia, the United States, and the United Kingdom,
the scanty awareness of NTT among Indian ENT specialists is a titanic setback for care
providers. Because of this backdrop, this review emphasized the current perspectives on tinnitus
management and the underlying principles and clinical efficacy of NTT. The challenges for tinnitus
management can be met and reduced by suppressing tinnitus through motivation, counseling,
cochlear implant, and psychotherapy.
Graphical Abstract
[1]
Hoffman HJ, Reed GW. Epidemiology of tinnitus. In: Snow JB, Ed. Tinnitus, theory and management. Lewiston, New York: BC Decker Inc 2004; pp. 16-41.
[11]
Davis A, Rafaie EA. Epidemiology of tinnitus. In: Tyler RS, Ed. Tinnitus handbook. San Diego, CA: Singular 2000; pp. 1-23.
[20]
Makar SK, Jalvi RR, Sinha AK. Study of nature and gender differences of a group of persons suffering from tinnitus. J All India Insti Speech Hear 2009; 28: 164-70.
[30]
Chung JH, Lee SH. The pathophysiologic mechanism of tinnitus. Hanyang Med Rev 2016; 36(2): 81-5.
[46]
Gupta JK, Kumar SS, Misra V, Patel K. Evaluation of antinociceptive and anti-inflammatory activity of Punicagranatum seed extract. Int Res J Pharm 2011; 2(12): 235-7.
[104]
Cobo P. Successful aplication of sound therapy to a patient with severe tinnitus: Case study. J Otolaryngol Head Neck Surg 2021; 7: 51.
[108]
Winkler PA. Tinnitus treatment. U.S. Patent 20140046230A1, 2014.
[109]
Fan-Gang Z, Qing T, Carroll JC. Devices and methods for suppression of tinnitus. Eur. Patent 2224987A1, 2015.
[110]
Lenhardt ML. Tinnitus masker/suppressor. U.S. Patent 20010051776A1, 2001.
[111]
Melman RO. System and method for tinnitus suppression. WIPO (PCT) WO2020188415A1, 2001.
[112]
Daniel M, Gilles K. Device for treating tinnitus. Eur. Patent 2958342A1, 2015.
[113]
Lim HH, Hamilton M, Guo H, Gloeckner C. Ultrasonic hearing system and related methods. U.S. Patent 10904676B2, 2021.
[114]
Searchfield GD, Kobayashi K, Irving S. Tinnitus treatment system and method. U.S. Patent 20180126115A1, 2018.
[115]
Mailman RO. Systems and methods for tinnitus suppression. Chinese Patent 113194897A, 2021.
[116]
Henry JA, Silaski G, Gray D, Porsov EV, Owens K. Method and apparatus for tinnitus evaluation. U.S. Patent 20130131542A1, 2013.
[117]
Micheyl CD. Method and apparatus for tinnitus evaluation with test sound automatically adjusted for loudness. U.S. Patent 10842418B2, 2020.
[118]
Goorevich M, Khing PP, Killian MJP, Van Dijk B. Tinnitus masking in hearing prostheses. WIPO (PCT) WO2017203396A1, 2017.
[119]
Marek P. Tinnitus fitting method in CI and ABI patients. U.S. Patent 9566435B2, 2017.